Orange Book product · Generic (ANDA)
ACETAZOLAMIDE
ACETAZOLAMIDE
At a glance
Jan 16, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 16, 2019
7 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
ACETAZOLAMIDE
Strength
500MG
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 205301
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of ACETAZOLAMIDE
- —DIAMOXBrand (NDA)
NDA 012945 · TEVA BRANDED PHARM
- —DIAMOXBrand (NDA)
NDA 008943 · TEVA BRANDED PHARM
- 2025ACETAZOLAMIDEGeneric (ANDA)
ANDA 212089 · AUROBINDO PHARMA LTD
- 2024ACETAZOLAMIDEGeneric (ANDA)
ANDA 218023 · EPIC PHARMA LLC
- 2024ACETAZOLAMIDEGeneric (ANDA)
ANDA 213706 · TORRENT
- 2023ACETAZOLAMIDEGeneric (ANDA)
ANDA 211151 · AJANTA PHARMA LTD
- 2023ACETAZOLAMIDEGeneric (ANDA)
ANDA 217197 · NE RX PHARMA
- 2023ACETAZOLAMIDEGeneric (ANDA)
ANDA 211069 · ZYDUS LIFESCIENCES
- 2021ACETAZOLAMIDEGeneric (ANDA)
ANDA 215101 · RUBICON RESEARCH
- 2021ACETAZOLAMIDEGeneric (ANDA)
ANDA 211372 · SOMERSET THERAPS LLC
- 2020ACETAZOLAMIDEGeneric (ANDA)
ANDA 214282 · MANKIND PHARMA
- 2020ACETAZOLAMIDEGeneric (ANDA)
ANDA 207401 · MICRO LABS LTD INDIA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
